|
CHMP4C expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.126400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.352200E-01 |
| Normal-vs-Stage2 |
5.521800E-01 |
| Normal-vs-Stage3 |
7.657600E-02 |
| Normal-vs-Stage4 |
1.398180E-01 |
| Stage1-vs-Stage2 |
4.994400E-01 |
| Stage1-vs-Stage3 |
7.369800E-02 |
| Stage1-vs-Stage4 |
1.402370E-01 |
| Stage2-vs-Stage3 |
2.943400E-01 |
| Stage2-vs-Stage4 |
1.634250E-01 |
| Stage3-vs-Stage4 |
6.382000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.277800E-01 |
| Normal-vs-AfricanAmerican |
3.254000E-02 |
| Normal-vs-Asian |
2.518800E-01 |
| Caucasian-vs-AfricanAmerican |
3.520000E-02 |
| Caucasian-vs-Asian |
2.688600E-01 |
| AfricanAmerican-vs-Asian |
4.441000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.321600E-01 |
| Normal-vs-Female |
3.043800E-02 |
| Male-vs-Female |
2.156300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.807400E-01 |
| Normal-vs-Extreme_Weight |
5.534400E-01 |
| Normal-vs-Obese |
4.046000E-02 |
| Normal-vs-Extreme_Obese |
7.343400E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.927780E-01 |
| Normal_Weight-vs-Obese |
4.360400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.524400E-01 |
| Extreme_Weight-vs-Obese |
8.916100E-03 |
| Extreme_Weight-vs-Extreme_Obese |
9.680200E-01 |
| Obese-vs-Extreme_Obese |
2.150200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.279200E-03 |
| Normal-vs-Age(41-60Yrs) |
2.032400E-01 |
| Normal-vs-Age(61-80Yrs) |
9.729800E-01 |
| Normal-vs-Age(81-100Yrs) |
2.443600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.264400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.283400E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.303500E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.712970E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.067610E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.057000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.668800E-01 |
| Normal-VS-Type2 PRCC |
3.627800E-01 |
| Normal-VS-KIRP CIMP |
4.954600E-04 |
| Normal-VS-Unclassified PRCC |
9.046800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.574300E-02 |
| Type1 PRCC-VS-KIRP CIMP |
8.604800E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
4.000400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.8728000261703E-09 |
| Type2 PRCC-VS-Unclassified PRCC |
5.340200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.151800E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.658800E-01 |
| Normal-vs-N1 |
3.882700E-03 |
| Normal-vs-N2 |
8.488600E-01 |
| N0-vs-N1 |
1.197240E-03 |
| N0-vs-N2 |
9.187400E-01 |
| N1-vs-N2 |
1.654820E-01 |
|
|
